These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 21428846)

  • 21. Squalamine analogues as potential anti-trypanosomal and anti-leishmanial compounds.
    Khabnadideh S; Tan CL; Croft SL; Kendrick H; Yardley V; Gilbert IH
    Bioorg Med Chem Lett; 2000 Jun; 10(11):1237-9. PubMed ID: 10866389
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and characterization of a pyridine-2-thiol N-oxide gold(I) complex with potent antiproliferative effect against Trypanosoma cruzi and Leishmania sp. insight into its mechanism of action.
    Vieites M; Smircich P; Guggeri L; Marchán E; Gómez-Barrio A; Navarro M; Garat B; Gambino D
    J Inorg Biochem; 2009 Oct; 103(10):1300-6. PubMed ID: 19361864
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trypanosomes at the gates.
    Cross GA
    Science; 2005 Jul; 309(5733):355. PubMed ID: 16020696
    [No Abstract]   [Full Text] [Related]  

  • 24. Development of novel drugs for human African trypanosomiasis.
    Brun R; Don R; Jacobs RT; Wang MZ; Barrett MP
    Future Microbiol; 2011 Jun; 6(6):677-91. PubMed ID: 21707314
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potential Drug Targets in the Pentose Phosphate Pathway of Trypanosomatids.
    Loureiro I; Faria J; Santarem N; Smith TK; Tavares J; Cordeiro-da-Silva A
    Curr Med Chem; 2018; 25(39):5239-5265. PubMed ID: 29210635
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Collaborative actions in anti-trypanosomatid chemotherapy with partners from disease endemic areas.
    Dujardin JC; González-Pacanowska D; Croft SL; Olesen OF; Späth GF
    Trends Parasitol; 2010 Aug; 26(8):395-403. PubMed ID: 20538522
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of trypanosomiasis and leishmaniasis.
    Barrett MP; Croft SL
    Br Med Bull; 2012; 104(1):175-96. PubMed ID: 23137768
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The use of Sulfonamide Derivatives in the Treatment of Trypanosomatid Parasites including Trypanosoma cruzi, Trypanosoma brucei, and Leishmania ssp.
    Scarim CB; Chelucci RC; Dos Santos JL; Chin CM
    Med Chem; 2020; 16(1):24-38. PubMed ID: 31218962
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New leads for trypanosomiasis chemotherapy.
    Lancet; 1978 Dec; 2(8101):1190. PubMed ID: 82152
    [No Abstract]   [Full Text] [Related]  

  • 30. Parasite prolyl oligopeptidases and the challenge of designing chemotherapeuticals for Chagas disease, leishmaniasis and African trypanosomiasis.
    Bastos IM; Motta FN; Grellier P; Santana JM
    Curr Med Chem; 2013; 20(25):3103-15. PubMed ID: 23514419
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Screening a Natural Product-Based Library against Kinetoplastid Parasites.
    Zulfiqar B; Jones AJ; Sykes ML; Shelper TB; Davis RA; Avery VM
    Molecules; 2017 Oct; 22(10):. PubMed ID: 29023425
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biphenylquinuclidines as inhibitors of squalene synthase and growth of parasitic protozoa.
    Orenes Lorente S; Gómez R; Jiménez C; Cammerer S; Yardley V; de Luca-Fradley K; Croft SL; Ruiz Perez LM; Urbina J; Gonzalez Pacanowska D; Gilbert IH
    Bioorg Med Chem; 2005 May; 13(10):3519-29. PubMed ID: 15848765
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design and synthesis of a series of melamine-based nitroheterocycles with activity against Trypanosomatid parasites.
    Baliani A; Bueno GJ; Stewart ML; Yardley V; Brun R; Barrett MP; Gilbert IH
    J Med Chem; 2005 Aug; 48(17):5570-9. PubMed ID: 16107157
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytotoxicity of (2,2':6',2''-terpyridine)platinum(II) complexes to Leishmania donovani, Trypanosoma cruzi, and Trypanosoma brucei.
    Lowe G; Droz AS; Vilaivan T; Weaver GW; Tweedale L; Pratt JM; Rock P; Yardley V; Croft SL
    J Med Chem; 1999 Mar; 42(6):999-1006. PubMed ID: 10090783
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Challenges in drug discovery targeting TriTryp diseases with an emphasis on leishmaniasis.
    Alcântara LM; Ferreira TCS; Gadelha FR; Miguel DC
    Int J Parasitol Drugs Drug Resist; 2018 Dec; 8(3):430-439. PubMed ID: 30293058
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel azasterols as potential agents for treatment of leishmaniasis and trypanosomiasis.
    Lorente SO; Rodrigues JC; Jiménez Jiménez C; Joyce-Menekse M; Rodrigues C; Croft SL; Yardley V; de Luca-Fradley K; Ruiz-Pérez LM; Urbina J; de Souza W; González Pacanowska D; Gilbert IH
    Antimicrob Agents Chemother; 2004 Aug; 48(8):2937-50. PubMed ID: 15273104
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-trypanosomal activities of DNA topoisomerase inhibitors.
    Deterding A; Dungey FA; Thompson KA; Steverding D
    Acta Trop; 2005 Mar; 93(3):311-6. PubMed ID: 15715983
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel chemical starting points for drug discovery in leishmaniasis and Chagas disease.
    Roquero I; Cantizani J; Cotillo I; Manzano MP; Kessler A; Martín JJ; McNamara CW
    Int J Parasitol Drugs Drug Resist; 2019 Aug; 10():58-68. PubMed ID: 31158574
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and antikinetoplastid activity of a series of N,N'-substituted diamines.
    Caminos AP; Panozzo-Zenere EA; Wilkinson SR; Tekwani BL; Labadie GR
    Bioorg Med Chem Lett; 2012 Feb; 22(4):1712-5. PubMed ID: 22248858
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of African trypanosomiasis with cordycepin and adenosine deaminase inhibitors in a mouse model.
    Rottenberg ME; Masocha W; Ferella M; Petitto-Assis F; Goto H; Kristensson K; McCaffrey R; Wigzell H
    J Infect Dis; 2005 Nov; 192(9):1658-65. PubMed ID: 16206083
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.